Author: OurCrowd

[BrightInsight in PR Newswire] Havas Health and BrightInsight forge exclusive alliance to tackle pharma’s $500B+ patient problem

Feb 26, 2026 |

NEW YORK, Feb. 26, 2026 /PRNewswire/ – Havas Health today announced an exclusive, strategic partnership with BrightInsight, the leading global platform for biopharma to deliver digital persistence and adherence solutions. This collaboration designates Havas Health as BrightInsight’s single global agency partner, creating a first-of-its-kind offering that merges world-class healthcare strategy and creativity with a compliant, scalable digital health platform to support and retain the patient post-prescription. Read...

Read More

[TensorWave in PR Newswire] TensorWave partners with Credo to power next-generation AMD-based AI clusters

Feb 25, 2026 |

SAN JOSE, Calif.–(BUSINESS WIRE)– Credo Technology Group Holding Ltd (Credo) (NASDAQ: CRDO), an innovator in providing connectivity at scale through fast, reliable, and energy-efficient system solutions, today announced a collaboration with TensorWave, the AMD-exclusive AI cloud provider, to deploy Credo’s ZeroFlap (ZF) family of Active Electrical Cables (AECs) and Optics across TensorWave’s next-generation AI cluster infrastructure. The collaboration supports TensorWave’s mission to deliver faster time to first token, higher cluster utilization, and production-grade reliability at scale. Read...

Read More

[Scopio in PR Newswire] Scopio Labs achieves EU IVDR Certification for AI-Powered Full-Field Digital Morphology Platforms

Feb 25, 2026 |

PARSIPPANY, N.J., Feb. 25, 2026 /PRNewswire/ — Scopio Labs today announced it has achieved IVDR certification from BSI, a major regulatory milestone that clears the path for its AI-driven digital morphology platforms in the European Union. The certification covers the company’s QMS and full technical documentation for the X100 and X100HT platforms, including its Full-Field Peripheral Blood Smear (FF-PBS) Application with RBC AI-powered decision support. By meeting these rigorous EU standards, Scopio solidifies its position as a pioneer in Full-Field digital cell morphology, ensuring its technology meets the world’s most stringent medical device safety standards. Read more...

Read More